Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

$CELC

Celcuity Inc. Common Stock

XNASHealth CareServices-Medical Laboratories

$93.88+1.03%+$0.9550Prev $92.92LIVE Full chart Live alerts
No recent price bars, the chart lights up when CELC starts printing.

Why is CELC up today? It is at $93.88 (+1.03%), and our scanner flagged it 39 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CELC spikes, and full due diligence on CELC — key stats, earnings, dilution and insider activity. Free.

Free alerts

Get free $CELC alerts the moment volume spikes

Our scanner flagged $CELC 39 times in the last 30 days. Create a free account to track $CELC, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Key Stats

Price & performance
Price
$93.88
Change today
+1.03%
Previous close
$92.92
52-week range
$42.88 – $151.02
Valuation & dividend
Market cap
$4.53B
Ownership & volume
Shares outstanding
48.8M
SEC · as of 2026-05-07 · 91d
Insider ownership
13.8%
DEF 14A · 2026-04-02
Institutional own.
99.9%
Total held
100.0%
Short interest
11.2M
▲ +2% vs prior · as of 2026-07-15
Days to cover
5.7d
Avg daily volume
1.1M
Next earnings
Aug 13 · in 7d
Classification
Sector
Health Care
Industry
Services-Medical Laboratories
Exchange
XNAS
Relative volumevs this time of day
5m
0.4x
15m
0.8x
1h
0.8x
1D
0.1x

Get free CELC + market alerts in your inbox

The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Why is $CELC up today?

Here is the latest on CELC from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CELC today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

Likely catalystClinical / FDA update, from the latest SEC filing. Read it →
Why is $CELC moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profile📅 Earnings in 7d⚡ Ultra-low floatShortableEasy to borrowNo SSRBorrow via Alpaca · SSR from Reg SHO 201
Wall Street consensusStrong Buy9 analysts
Avg target $165.00(+76% upside)
Range $147 – $178
9 buy0 hold0 sell

Analyst data via Nasdaq. Not investment advice.

Insiders

Insiders buying7 buys, 2 sells last 3 months (9/14 over 12 months)
Show 12 recent transactions
InsiderActionShares% of positionOwns afterValueDate
Baker Bros. Advisors Lp
Other
Sold (automatic/other)-3.10M
6.4% of company
sold 39%4.82M$317.8M
at $102.50
Jul 14, 26
Buller Richard E
Director
Acquired (grant/award)+2Kn/a2Kn/aJun 5, 26
Nigon Richard
Director
Acquired (grant/award)+2Kadded 1.9%81Kn/aJun 5, 26
Romp Charles R
Director
Acquired (grant/award)+2Kadded 100%2Kn/aJun 5, 26
Furcht Leo
Director
Acquired (grant/award)+2Kadded 14%13Kn/aJun 5, 26
Dalvey David
Director
Acquired (grant/award)+2Kn/a2Kn/aJun 5, 26
Murphy Polly A.
Director
Acquired (grant/award)+2Kadded 31%7Kn/aJun 5, 26
Laing Lance G.
Officer
Other1Kadded <0.1%1.25M$10K
at $9.89
Jun 2, 26
Buller Richard E
Director
Sold (automatic/other)-1Kn/an/an/aMay 19, 26
Buller Richard E
Director
Acquired (grant/award)+1Kadded 15%8Kn/aMay 19, 26
Buller Richard E
Director
Sold (automatic/other)-9K
0.02% of company
sold 57%7K$1.2M
at $137.00
May 4, 26
Buller Richard E
Director
Other9K
0.02% of company
added 100%16K$46K
at $5.10
May 4, 26

Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.

Dilution watch

Recent offering

Recent priced share offering — a one-time sale that has already completed (not ongoing). If $CELC runs, these filings show who may be positioned to sell new or newly-registered shares into the move.

Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.

$CELC Sentiment

Neutral
Bearish53Bullish
📰 News: 2 bull · 2 bearToday: +1.0%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$CELC Activity

News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.

Alert· 1d ago +3.9% vs EMA
CELC 200EMA (5m) Trending · 76 bars · L3 · +3.88% above EMA · slope +0.91%
at $92.63
Alert· 1d ago +0.6% vs EMA
CELC 50EMA (5m) Trending · 76 bars · L3 · +0.57% above EMA · slope +0.92%
at $92.63
Alert· 1d ago +1.3% vs EMA
CELC 200EMA (1m) Trending · 212 bars · L5 · +1.26% above EMA · slope +0.30%
at $92.63
Alert· 1d ago +1.3% vs EMA
CELC 200EMA (1m) Trending · 212 bars · L5 · +1.26% above EMA · slope +0.30%
at $92.63
Alert· 1d ago +1.3% vs EMA
CELC 200EMA (1m) Trending · 212 bars · L5 · +1.26% above EMA · slope +0.30%
at $92.63
Alert· 1d ago +2.3% vs EMA
$CELC near 200 EMA: +2.28% from 200 EMA at 2:42 PM ET
at $93.21
Alert· 1d ago 18.4× RVOL
CELC hit 18.411x RVOL at 2:42 PM ET
at $93.21
Alert· 1d ago +2.9% vs EMA
$CELC near 200 EMA: +2.88% from 200 EMA at 11:57 AM ET
at $91.50
Alert· 1d ago 8.8× RVOL
CELC hit 8.849x RVOL at 11:57 AM ET
at $91.50
Alert· 1d ago +1.0% vs EMA
CELC 50EMA (1m) Trending · 73 bars · L3 · +1.05% above EMA · slope +0.96%
at $91.25
Alert· 1d ago 6.8× RVOL
CELC hit 6.746x RVOL at 11:26 AM ET
at $90.87
Alert· 6d ago +1.03%
$CELC moved +1.03% in 1 min (Level 1) at 9:58 AM ET
at $86.95
Alert· 6d ago +4.3% vs EMA
CELC 200EMA (5m) Trending · 80 bars · L3 · +4.33% above EMA · slope +0.67%
at $87.69
Alert· 6d ago +2.0% vs EMA
CELC 50EMA (5m) Trending · 77 bars · L3 · +2.03% above EMA · slope +1.01%
at $87.69
Alert· 6d ago +2.3% vs EMA
CELC 200EMA (1m) Trending · 185 bars · L4 · +2.34% above EMA · slope +0.31%
at $87.69
Alert· 6d ago +2.3% vs EMA
CELC 200EMA (1m) Trending · 185 bars · L4 · +2.34% above EMA · slope +0.31%
at $87.69
Alert· 6d ago +1.4% vs EMA
$CELC near 200 EMA: +1.45% from 200 EMA at 2:08 PM ET
at $86.27
Alert· 6d ago 22.3× RVOL
CELC hit 22.332x RVOL at 2:08 PM ET
at $86.27
Alert· 6d ago +2.4% vs EMA
$CELC near 200 EMA: +2.39% from 200 EMA at 1:51 PM ET
at $86.88
Alert· 6d ago 2.0× RVOL
CELC hit 2.000x RVOL at 1:51 PM ET
at $86.88
Alert· 6d ago +0.2% vs EMA
$CELC near 200 EMA: +0.16% from 200 EMA at 12:46 PM ET
at $84.44
Alert· 6d ago 6.3× RVOL
CELC hit 6.264x RVOL at 12:46 PM ET
at $84.44
Alert· 7d ago +1.0% vs EMA
CELC 200EMA (1m) Trending · 68 bars · L3 · +1.00% above EMA · slope +0.31%
at $83.22
Alert· 7d ago +1.0% vs EMA
CELC 200EMA (1m) Trending · 68 bars · L3 · +1.00% above EMA · slope +0.31%
at $83.22
Alert· 7d ago 2.0× RVOL
CELC hit 2.000x RVOL at 3:54 PM ET
at $82.68
News· GlobeNewswire Inc.· 8d ago Bearish
NASDAQ: CELC Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Celcuity Inc. (NASDAQ: CELC) Investors to Contact the Firm
News· GlobeNewswire Inc.· 15d ago Bearish
CELCUITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Celcuity Inc. on Behalf of Celcuity Stockholders and Encourages Investors to Contact the Firm
News· SEC EDGAR· 21d ago
Celcuity Inc.: Announces FDA Approval of REVTORPYK&trade; (gedatolisib) for the Treatment of HR+/HER2-, PIK3CA Wild-Type Locally Advanced or Metastatic
News· SEC EDGAR· 22d ago
Celcuity Inc. filed an 8-K: Regulation FD Disclosure, Other Material Event
News· GlobeNewswire Inc.· 22d ago Bullish
Celcuity Announces FDA Approval of REVTORPYK™ (gedatolisib) for the Treatment of HR+/HER2-, PIK3CA Wild-Type Locally Advanced or Metastatic Breast Cancer
News· SEC EDGAR· 58d ago
Celcuity Inc. filed an 8-K: Material Agreement, Agreement Terminated, New Financial Obligation, Other Material Event
News· GlobeNewswire Inc.· 63d ago Bullish
Celcuity Inc. Announces Pricing of Upsized Public Offering of 0.250% Convertible Senior Notes Due 2032
News· SEC EDGAR· 65d ago
Celcuity Inc. filed an 8-K: Regulation FD Disclosure, Other Material Event

Related SERVICES-MEDICAL stocks

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

CELC stock FAQ

Why is $CELC up today?

Here is the latest on CELC from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CELC today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

What is the CELC stock price today?

CELC last traded at $93.88, up 1.03% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

When does CELC report earnings?

Celcuity Inc. Common Stock (CELC) is next expected to report earnings on Thursday, August 13, 2026, about 7 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.

Where can I see live CELC alerts?

The CELC Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CELC 39 times in the last 30 days.

What exchange is CELC on?

CELC (Celcuity Inc. Common Stock) trades on XNAS, with a market cap of about $4.53B in the SERVICES-MEDICAL LABORATORIES sector.

Is CELC good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CELC for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.